This paper proposes a new method for analysis of adverse event data in clinical trials. The method is illustrated by application to data on 4 phase III clinical trials, two on breast cancer and two on diabetes mellitus.
@article{arxiv.1806.00204,
title = {Adversity Index for Clinical Trials: An Inclusive Approach for Analysis of Safety Data},
author = {Sharayu Paranjpe and Anil Gore},
journal= {arXiv preprint arXiv:1806.00204},
year = {2018}
}